东亚药业 (605177.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 2.37B

MomentumView details →

1D Return

−0.43%

YTD Return

+23.43%

RSI (14)

66.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 2.37B

RSI (14)

66.4

MomentumView details →

1D Return

−0.43%

YTD Return

+23.43%

ProfitabilityView details →

Gross Margin

20.81%

Net Margin

−10.92%

EBITDA Margin

7.04%

ROE (TTM)

−6.24%

ROA (TTM)

−3.42%

Asset Turnover

0.31x

GrowthView details →

Revenue YoY

−2.19%

EPS YoY

+17.97%

FCF YoY

+62.45%

Revenue CAGR 3Y

−7.28%

EPS CAGR 3Y

+20.00%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.20x

Current Ratio

1.87x

Quick Ratio

1.11x

Div Yield

—

Div Rate

—

Div Growth 1Y

+12.63%

Financials snapshotView financials →

Revenue (TTM)

1.01B

Net Income (TTM)

−110.67M

Op. CF (TTM)

−102.19M

Latest newsMore news →

No recent news for 605177.SH.

Similar companies

Biohaven Ltd.BHVN Sarepta Therapeutics, Inc.SRPT Nuvation Bio Inc.NUVB Ocular Therapeutix, Inc.OCUL Shanghai Bao Pharmaceuticals Co., Ltd.02659.HK AIM Vaccine Co., Ltd.06660.HK Find similar companies →

Latest newsMore news →

No recent news for 605177.SH.